Schwabe Group
Andreas Becker has extensive work experience in the pharmaceutical and healthcare industry. Andreas currently holds the position of Vice President Global Brand and Health Interest Strategy at Schwabe Group, where they have been working since 2013. Prior to this, Andreas worked as the Director Global Strategy General Health & Wellbeing and Marketing Manager Global Innovation and New Products at Schwabe Group. Andreas also served as a Senior Global Product Manager at the company.
Before joining Schwabe Group, Andreas worked as a Global Brand Manager Dermatology at Merz Pharmaceuticals from 2012 to 2013. Prior to that, they held various roles at GSK, including Product Manager and Brand Manager North & West Europe from 2006 to 2012. Andreas also gained experience as a Brand Consultant Intern at Merck Group and as a Product Management Intern at Beiersdorf in 2005.
Andreas Becker completed their education at Pforzheim University from 2001 to 2006, earning a degree in Diplom-Betriebswirt with a focus on BWL/Marketing/Kommunikation. Additionally, they participated in a semester abroad at Tecnológico de Monterrey, studying International Business. In terms of additional certifications, Andreas is currently enrolled in Leadership Training at St. Gallen Business School, with an expected completion date in 2023.
Schwabe Group
The Schwabe Group comprises several different affiliated companies in the pharmaceutical and health industry. All of the companies within the Group focus on plants as the basis for developing pharmaceuticals and health products. The original form of the Group’s parent company, which is now Dr. Willmar Schwabe GmbH & Co. KG, is one of the oldest pharmaceutical manufacturers in Europe and has a company history dating back over 150 years. We do so by researching and developing plant-based medicines and health-care products. Our goal is to create value through innovation. We believe that innovative phytomedicines will become increasingly important over the next few decades. By influencing several target systems in the body at the same time, they may be more appropriate for patients suffering from complex or age-related diseases than is the “silver bullet” approach of synthetic medicines. In the future, phytomedicines will help people, worldwide, to lead a sustainable, productive and healthy life. We are actively shaping the company’s international future in a changing and challenging global market. Our goal is to maintain our market-leadership in phytomedicines by introducing our products into new markets, expanding our network of affiliates and distribution partners, and providing more extensive access to our health-care solutions. The commitment, experience and creativity of our employees are the source of our success. At Schwabe Pharmaceuticals we share a common vision: “From Nature. For Health”. We would like to invite you to learn more about this vision and our company on this website.